•ThispresentationisbasedoncontentpresentedattheExplorationSafety RoadshowheldinAugust2009 •Itismadeavailablefornon-commercialuse(e.g.toolboxmeetings)subjectto theconditionthatthePowerPointfileisnotaltered
above all studies demonstrated acceptable biocompatibility and safety in cell or small animal models [236,237,238,239,240]. The fact that the excitation light source NIR is administered solely in the tumor region and that the nanoparticles generally have passive tumor...
ArticleCASPubMedPubMed CentralGoogle Scholar Mahalingam, D.et al. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors.Autophagy10, ...